ENZC (Enzolytics) ROCE %: 0.00% (As of Jun. 2011)


What is Enzolytics ROCE %?

Enzolytics ENZC -9.09% ROCE % is 0.00% as of Jun. 2011.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Enzolytics's annualized ROCE % for the quarter that ended in Jun. 2011 was 0.00%.

Enzolytics  (OTCPK:ENZC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Enzolytics ROCE % Related Terms

Enzolytics ROCE % Historical Data

* Premium members only.

The historical data trend for Enzolytics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics ROCE % Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
ROCE %
0.00 0.00 0.00 0.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enzolytics ROCE % Calculation

Enzolytics's annualized ROCE % for the fiscal year that ended in Dec. 2010 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2010 )  (A: Dec. 2009 )(A: Dec. 2010 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2010 )  (A: Dec. 2009 )(A: Dec. 2010 )
=-7.445/( ( (0.085 - 1.274) + (0.153 - 0.677) )/ 2 )
=-7.445/( (-1.189+-0.524)/ 2 )
=-7.445/-0.8565
=869.24 %

Enzolytics's ROCE % of for the quarter that ended in Jun. 2011 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2011 )  (Q: Mar. 2011 )(Q: Jun. 2011 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2011 )  (Q: Mar. 2011 )(Q: Jun. 2011 )
=-0.856/( ( (0.137 - 0.776) + (0.112 - 0.778) )/ 2 )
=-0.856/( ( -0.639 + -0.666 )/ 2 )
=-0.856/-0.6525
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2011) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Enzolytics (ENZC) has a ROCE % of 0.00% as of Jun. 2011.
Is Enzolytics' ROCE % too high?
Enzolytics' current ROCE % is 0.00%.
How does Enzolytics' ROCE % compare to competitors?
Enzolytics' ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Enzolytics's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Enzolytics (ENZC), the current ROCE % is 0.00% as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.